221 related articles for article (PubMed ID: 24653954)
41. Insulinotropic and antidiabetic effects of 17β-estradiol and the GPR30 agonist G-1 on human pancreatic islets.
Kumar R; Balhuizen A; Amisten S; Lundquist I; Salehi A
Endocrinology; 2011 Jul; 152(7):2568-79. PubMed ID: 21521748
[TBL] [Abstract][Full Text] [Related]
42. Anxiolytic-like effect of way-100635 microinfusions into the median (but not dorsal) raphe nucleus in mice exposed to the plus-maze: influence of prior test experience.
Canto-de-Souza A; Luiz Nunes-de-Souza R; Rodgers RJ
Brain Res; 2002 Feb; 928(1-2):50-9. PubMed ID: 11844471
[TBL] [Abstract][Full Text] [Related]
43. Involvement of the ventral, but not dorsal, hippocampus in anxiety-like behaviors in mice exposed to the elevated plus maze: participation of CRF1 receptor and PKA pathway.
Bertagna NB; Dos Santos PGC; Queiroz RM; Fernandes GJD; Cruz FC; Miguel TT
Pharmacol Rep; 2021 Feb; 73(1):57-72. PubMed ID: 33175366
[TBL] [Abstract][Full Text] [Related]
44. Postpartum estrogen withdrawal impairs GABAergic inhibition and LTD induction in basolateral amygdala complex via down-regulation of GPR30.
Yang R; Zhang B; Chen T; Zhang S; Chen L
Eur Neuropsychopharmacol; 2017 Aug; 27(8):759-772. PubMed ID: 28619359
[TBL] [Abstract][Full Text] [Related]
45. Ventral hippocampal histamine increases the frequency of evoked theta rhythm but produces anxiolytic-like effects in the elevated plus maze.
Yeung M; Treit D; Dickson CT
Neuropharmacology; 2016 Jul; 106():146-55. PubMed ID: 26400409
[TBL] [Abstract][Full Text] [Related]
46. Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis.
Filardo EJ; Quinn JA; Frackelton AR; Bland KI
Mol Endocrinol; 2002 Jan; 16(1):70-84. PubMed ID: 11773440
[TBL] [Abstract][Full Text] [Related]
47. Inhibition of brain 17β-estradiol synthesis by letrozole induces cognitive decline in male and female rats.
Marbouti L; Zahmatkesh M; Riahi E; Sadr SS
Neurobiol Learn Mem; 2020 Nov; 175():107300. PubMed ID: 32882397
[TBL] [Abstract][Full Text] [Related]
48. Ventral Hippocampus Modulates Anxiety-Like Behavior in Male But Not Female C57BL/6 J Mice.
Wang C; Zhang Y; Shao S; Cui S; Wan Y; Yi M
Neuroscience; 2019 Oct; 418():50-58. PubMed ID: 31461661
[TBL] [Abstract][Full Text] [Related]
49. Region specific gene expression profile in mouse brain after chronic corticotropin releasing factor receptor 1 activation: the novel role for diazepam binding inhibitor in contextual fear conditioning.
Sherrin T; Blank T; Saravana R; Rayner M; Spiess J; Todorovic C
Neuroscience; 2009 Aug; 162(1):14-22. PubMed ID: 19362130
[TBL] [Abstract][Full Text] [Related]
50. G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation.
Chakrabarti S; Davidge ST
PLoS One; 2012; 7(12):e52357. PubMed ID: 23285008
[TBL] [Abstract][Full Text] [Related]
51. [D2-subtype of dopaminergic receptors is involved in anxiety behavior in ovariectomized rats].
Fedotova IuO
Patol Fiziol Eksp Ter; 2008; (3):10-3. PubMed ID: 18942469
[TBL] [Abstract][Full Text] [Related]
52. Analyzing the influence of BDNF heterozygosity on spatial memory response to 17β-estradiol.
Wu YW; Du X; van den Buuse M; Hill RA
Transl Psychiatry; 2015 Jan; 5(1):e498. PubMed ID: 25603414
[TBL] [Abstract][Full Text] [Related]
53. Attenuation of anxiety-related behaviour after the antagonism of transient receptor potential vanilloid type 1 channels in the rat ventral hippocampus.
Santos CJ; Stern CA; Bertoglio LJ
Behav Pharmacol; 2008 Jul; 19(4):357-60. PubMed ID: 18622185
[TBL] [Abstract][Full Text] [Related]
54. Cananga odorata essential oil reverses the anxiety induced by 1-(3-chlorophenyl) piperazine through regulating the MAPK pathway and serotonin system in mice.
Zhang N; Zhang L; Feng L; Yao L
J Ethnopharmacol; 2018 Jun; 219():23-30. PubMed ID: 29545208
[TBL] [Abstract][Full Text] [Related]
55. Differential effects of exogenous and endogenous estrogen on anxiety as measured by elevated T-maze in relation to the serotonergic system.
Pandaranandaka J; Poonyachoti S; Kalandakanond-Thongsong S
Behav Brain Res; 2009 Mar; 198(1):142-8. PubMed ID: 19046994
[TBL] [Abstract][Full Text] [Related]
56. Involvement of opioidergic system of the ventral hippocampus, the nucleus accumbens or the central amygdala in anxiety-related behavior.
Zarrindast MR; Babapoor-Farrokhran S; Babapoor-Farrokhran S; Rezayof A
Life Sci; 2008 Jun; 82(23-24):1175-81. PubMed ID: 18456284
[TBL] [Abstract][Full Text] [Related]
57. Anxiolytic effects of 5-HT₁A receptors and anxiogenic effects of 5-HT₂C receptors in the amygdala of mice.
Li Q; Luo T; Jiang X; Wang J
Neuropharmacology; 2012 Jan; 62(1):474-84. PubMed ID: 21925519
[TBL] [Abstract][Full Text] [Related]
58. Long-term estrogen deprivation changes the response to antianxiety drugs in mice in the elevated plus maze test.
Xu H; Li W; Zhang B; Huang S; Liu X
Gynecol Endocrinol; 2019 Dec; 35(12):1054-1058. PubMed ID: 31192745
[TBL] [Abstract][Full Text] [Related]
59. Estrogen, predominantly via estrogen receptor α, attenuates postpartum-induced anxiety- and depression-like behaviors in female rats.
Furuta M; Numakawa T; Chiba S; Ninomiya M; Kajiyama Y; Adachi N; Akema T; Kunugi H
Endocrinology; 2013 Oct; 154(10):3807-16. PubMed ID: 23913447
[TBL] [Abstract][Full Text] [Related]
60. Estrogens induce rapid cytoskeleton re-organization in human dermal fibroblasts via the non-classical receptor GPR30.
Carnesecchi J; Malbouyres M; de Mets R; Balland M; Beauchef G; Vié K; Chamot C; Lionnet C; Ruggiero F; Vanacker JM
PLoS One; 2015; 10(3):e0120672. PubMed ID: 25781607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]